Latest News

January 21, 2011
The UCSF community recognized the stellar efforts of a student as well as faculty and staff members at the annual Martin Luther King, Jr. Awards on Jan. 25.
December 13, 2010
UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- “Hair to Stay” -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.
November 29, 2010
In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer.
November 09, 2010
Smoking in women with breast cancer increases breast cancer deaths and deaths overall, according to preliminary research results presented by UCSF epidemiologist Dejana Braithwaite, PhD, at a meeting of the American Association for Cancer Research.
October 25, 2010
A UCSF cancer education project has received the 2010 Faith Fancher Award from the California Breast Cancer Research Program, as well as a $600,000 grant recognizing the best proposal focused on underserved populations.
September 24, 2010
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
September 21, 2010
Cancer and infertility can be a double blow. Many women become infertile following cancer treatment. And because more women are living longer thanks to modern chemotherapy and radiation treatment, more are later discovering that they cannot bear children.
June 07, 2010
A single dose of radiation administered during surgery is as effective for patients with early forms of breast cancer as standard radiation therapy that can take as long as six weeks, according to new research findings.
April 28, 2010
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
March 03, 2010
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.

Pages